| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,140 | 22,978 | 16,549 | 18,628 | | Cost of Revenue | 12,763 | 11,882 | 9,118 | 11,574 | | | Gross Profit | 13,377 | 11,096 | 7,431 | 7,054 | | | Operating Expenses | | Research Development | 6,928 | 6,808 | 6,583 | 7,669 | | Selling General and Administrative | 6,337 | 6,281 | 5,429 | 6,686 | | Non Recurring | 1,013 | 385 | 301 | 764 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (901) | (2,378) | (4,882) | (8,065) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 141 | 297 | 371 | 491 | | Earnings Before Interest And Taxes | (760) | (2,081) | (4,511) | (7,574) | | Interest Expense |
-
| (18) | 18 | 449 | | Income Before Tax | (760) | (2,063) | (4,529) | (8,023) | | Income Tax Expense | 256 | 426 | 679 | 8,030 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,016) | (2,489) | (5,208) | (16,053) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,016) | (2,489) | (5,208) | (16,053) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,016) | ($2,489) | ($5,208) | ($16,053) |
|
0.11% Nasdaq 0.00%
Income Statement
